Show simple item record

dc.contributor.authorPrice, James M
dc.contributor.authorWest, Catharine M L
dc.contributor.authorDixon, L. M.
dc.contributor.authorIyizoba-Ebozue, Z.
dc.contributor.authorGarcez, Kate
dc.contributor.authorLee, Lip W
dc.contributor.authorMcPartlin, Andrew J
dc.contributor.authorSlevin, F.
dc.contributor.authorSykes, Andrew J
dc.contributor.authorPrestwich, R. J. D.
dc.contributor.authorThomson, David J
dc.date.accessioned2022-06-22T07:18:32Z
dc.date.available2022-06-22T07:18:32Z
dc.date.issued2022en
dc.identifier.citationPrice JM, West CM, Dixon LM, Iyizoba-Ebozue Z, Garcez K, Lee LW, et al. Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study. Vol. 172, Radiotherapy and Oncology. Elsevier BV; 2022. p. 111–7.en
dc.identifier.pmid35595173en
dc.identifier.doi10.1016/j.radonc.2022.05.013en
dc.identifier.urihttp://hdl.handle.net/10541/625322
dc.description.abstractBackground and purpose: There is renewed interest in hypofractionated radiotherapy, but limited data and a lack of consensus to support use for head and neck cancer. In this multicentre analysis we compared outcomes for patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with conventional and accelerated, mildly hypofractionated radiotherapy without chemotherapy. Materials and methods: A multi-centre, observational study of consecutive OPSCCs treated between 2015 and 2018. Patients underwent curative-intent radiotherapy (oropharyngeal and bilateral neck) using conventionally fractionated (70 Gy in 35 fractions over 7 weeks, n = 97) or accelerated, mildly hypofractionated (65-66 Gy in 30 fractions over 6 weeks, n = 136) radiotherapy without chemotherapy. Locoregional control (LRC) and overall survival (OS) were compared. Patients alive and cancer-free at a minimum of 2 years post-radiotherapy (n = 151, 65%) were sent an MD Anderson Dysphagia Inventory (MDADI) questionnaire to assess swallow function. Results: LRC and OS were similar across schedules (p = 0.78 and 0.95 respectively, log-rank test). Enteral feeding rates during radiotherapy appeared higher in the 7-week group though this did not reach statistical significance (59% vs 48%, p = 0.08). Feeding rates were similar at 1 year post radiotherapy for both groups (10% vs 6%, p = 0.27). 107 patients returned MDADI questionnaires (71%); there were no differences between the 6- and 7-week groups for median global (60.0 vs 60.0, p = 0.99) and composite (65.8 vs 64.2, p = 0.44) MDADI scores. Conclusion: Patients with OPSCC treated with radiotherapy alone have similar swallowing outcomes, LRC and OS following accelerated, mild hypofractionation and standard fractionation schedules, supporting its use as a standard-of-care option for patients unsuitable for concurrent chemotherapy.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.radonc.2022.05.013en
dc.titleSimilar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre studyen
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalRadiotherapy and Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record